IL2 and neoplasm: Given that T cells in the tumor environment are frequently exhausted (31), we assessed if XmAb808 could rejuvenate hyporesponsive T cells, using a well-established model in which exhaustion is triggered by prolonged incubation of T cells with αCD3/αCD28 antibody–coated beads in the presence of IL2 (32, 33).